somatostatin-28 and Peripheral-Arterial-Disease

somatostatin-28 has been researched along with Peripheral-Arterial-Disease* in 1 studies

Other Studies

1 other study(ies) available for somatostatin-28 and Peripheral-Arterial-Disease

Article	Year
Vasoactive Biomarkers Associated With Long-Term Incidence of Symptomatic Peripheral Arterial Disease and Mortality. Angiology, 2021, Volume: 72, Issue:6 We evaluated if plasma biomarkers can predict incident peripheral arterial disease (PAD) and mortality in a longitudinal cohort study. Men (n = 3618) and women (n = 1542) were included in the Malmö Preventive Project and underwent analysis of: C-terminal endothelin-1 (CT-proET-1), N-Terminal prosomatostatin (NT-proSST), midregional proatrial natriuretic peptide (MR-proANP), procalcitonin (PCT), and copeptin. Participants were followed up for incident PAD and mortality until December 31, 2016. Median follow-up was 11.2 years (interquartile range 9.4-12.2). Cumulative incidence of PAD was 4.3% (221/5160), 4.5% in men (164/3618) and 3.7% in women (57/1542; Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Endothelin-1; Female; Glycopeptides; Humans; Incidence; Longitudinal Studies; Male; Peptide Fragments; Peripheral Arterial Disease; Predictive Value of Tests; Procalcitonin; Prognosis; Protein Precursors; Retrospective Studies; Risk Assessment; Risk Factors; Somatostatin; Sweden; Time Factors; Up-Regulation	2021

Article

Year

Vasoactive Biomarkers Associated With Long-Term Incidence of Symptomatic Peripheral Arterial Disease and Mortality.

Angiology, 2021, Volume: 72, Issue:6

We evaluated if plasma biomarkers can predict incident peripheral arterial disease (PAD) and mortality in a longitudinal cohort study. Men (n = 3618) and women (n = 1542) were included in the Malmö Preventive Project and underwent analysis of: C-terminal endothelin-1 (CT-proET-1), N-Terminal prosomatostatin (NT-proSST), midregional proatrial natriuretic peptide (MR-proANP), procalcitonin (PCT), and copeptin. Participants were followed up for incident PAD and mortality until December 31, 2016. Median follow-up was 11.2 years (interquartile range 9.4-12.2). Cumulative incidence of PAD was 4.3% (221/5160), 4.5% in men (164/3618) and 3.7% in women (57/1542;

Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Endothelin-1; Female; Glycopeptides; Humans; Incidence; Longitudinal Studies; Male; Peptide Fragments; Peripheral Arterial Disease; Predictive Value of Tests; Procalcitonin; Prognosis; Protein Precursors; Retrospective Studies; Risk Assessment; Risk Factors; Somatostatin; Sweden; Time Factors; Up-Regulation

2021